Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LBPSW Stock Summary
In the News
LBPSW Financial details
Company Rating
-
Market Cap
0
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
127
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
0.81
LT Debt / Equity
0.39
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-17.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0442-0.0442
52W High
-
52W Low
-
RSI
52.68
Rel Volume
-
Avg Volume
-
Volume
Perf Week
16.67%
Perf Month
133.33%
Perf Quarter
-
Perf Half Y
133.33%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0035
Change
0%
LBPSW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0.03 | 0.04 | 0.03 | |
Net income per share | -2.51 | -2.89 | -2.94 | -1.82 | -1.51 | |
Operating cash flow per share | -2.11 | -2.8 | -2.63 | -1.59 | -1.79 | |
Free cash flow per share | -2.37 | -2.87 | -2.71 | -1.61 | -1.8 | |
Cash per share | 6.15 | 3.2 | 0.47 | 0.62 | 0.99 | |
Book value per share | 8.58 | 5.59 | 2.73 | 1.97 | 1.53 | |
Tangible book value per share | 6.77 | 3.83 | 1.02 | 0.98 | 0.63 | |
Share holders equity per share | 8.58 | 5.59 | 2.73 | 1.97 | 1.53 | |
Interest debt per share | 0.02 | 0.05 | 0.2 | 0.09 | 0.63 | |
Market cap | 87.59M | 93.54M | 90.18M | 151.91M | 85.56M | |
Enterprise value | 75.76M | 77.51M | 87.46M | 144.2M | 77.39M | |
P/E ratio | -4.28 | -3.95 | -3.75 | -5.85 | -2.68 | |
Price to sales ratio | 0 | 0 | 427.4 | 284.48 | 119.16 | |
POCF ratio | -5.1 | -4.08 | -4.18 | -6.7 | -2.26 | |
PFCF ratio | -4.55 | -3.98 | -4.07 | -6.65 | -2.24 | |
P/B Ratio | 1.26 | 2.04 | 4.04 | 5.43 | 2.64 | |
PTB ratio | 1.26 | 2.04 | 4.04 | 5.43 | 2.64 | |
EV to sales | 0 | 0 | 414.49 | 270.03 | 107.78 | |
Enterprise value over EBITDA | -3.31 | -2.88 | -3.17 | -4.98 | -2.58 | |
EV to operating cash flow | -4.41 | -3.38 | -4.06 | -6.36 | -2.04 | |
EV to free cash flow | -3.93 | -3.3 | -3.95 | -6.31 | -2.03 | |
Earnings yield | -0.23 | -0.25 | -0.27 | -0.17 | -0.37 | |
Free cash flow yield | -0.22 | -0.25 | -0.25 | -0.15 | -0.45 | |
Debt to equity | 0.11 | 0.15 | 0.37 | 0.27 | 0.81 | |
Debt to assets | 0.1 | 0.13 | 0.27 | 0.21 | 0.45 | |
Net debt to EBITDA | 0.52 | 0.6 | 0.1 | 0.27 | 0.27 | |
Current ratio | 11.6 | 6.4 | 1.8 | 2.59 | 5.21 | |
Interest coverage | -267.48 | -103.45 | -80.69 | -237.73 | -64.13 | |
Income quality | 0.84 | 0.97 | 0.9 | 0.87 | 1.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 7.45 | 7.67 | 22.13 | |
Research and developement to revenue | 0 | 0 | 125.65 | 41.28 | 30.13 | |
Intangibles to total assets | 0.19 | 0.27 | 0.46 | 0.4 | 0.33 | |
Capex to operating cash flow | 0.12 | 0.02 | 0.03 | 0.01 | 0.01 | |
Capex to revenue | 0 | 0 | -2.82 | -0.33 | -0.39 | |
Capex to depreciation | -2.12 | -0.45 | -0.46 | -0.15 | -0.21 | |
Stock based compensation to revenue | 0 | 0 | 1.27 | 6.24 | 0.99 | |
Graham number | 22.02 | 19.08 | 13.44 | 8.98 | 7.2 | |
ROIC | -0.54 | -1.62 | -1.56 | -2.41 | -2.45 | |
Return on tangible assets | -0.32 | -0.62 | -1.45 | -1.21 | -0.81 | |
Graham Net | 5.18 | 2.39 | -0.53 | 0.1 | -0.25 | |
Working capital | 52.82M | 27.98M | 5.01M | 10.27M | 27.88M | |
Tangible asset value | 55.11M | 31.32M | 8.36M | 13.95M | 13.27M | |
Net current asset value | 49.85M | 26.32M | 3.01M | 9.27M | 8.12M | |
Invested capital | 0 | 0 | 0.05 | 0.04 | 0.39 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.48M | 1.87M | 1.58M | 2.26M | 2.49M | |
Average inventory | 245.5K | 271.5K | 244K | 244.5K | 329.05K | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.29 | -0.52 | -1.08 | -0.93 | -0.99 | |
Capex per share | -0.26 | -0.07 | -0.07 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2021-12-31 for Q4
Metric | History | 2019-06-30 | 2020-06-30 | 2020-12-31 | 2021-06-30 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.01 | 0 | 0 | 0 | |
Net income per share | 0 | -0.3 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0.43 | 0 | 0 | 0 | |
Book value per share | 0 | 1.35 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 1.35 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 1.35 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0.05 | 0 | 0 | 0 | |
Market cap | 0 | 270.98M | 0 | 0 | 0 | |
Enterprise value | -11.8M | 262.05M | -7.72M | -19.74M | -8.17M | |
P/E ratio | 0 | -9.87 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 1.97K | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 8.61 | 0 | 0 | 0 | |
PTB ratio | 0 | 8.61 | 0 | 0 | 0 | |
EV to sales | 0 | 1.91K | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | -34.57 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | -0.03 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.22 | 0.27 | 0.27 | 0.2 | 0.81 | |
Debt to assets | 0.18 | 0.21 | 0.21 | 0.17 | 0.45 | |
Net debt to EBITDA | 0 | 1.18 | 0 | 0 | 0 | |
Current ratio | 6.62 | 3.16 | 2.59 | 4.22 | 5.21 | |
Interest coverage | 0 | 187.8 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 16.01 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 45.16 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.4 | 0 | 0.33 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | -0.58 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -0.26 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 3 | 0 | 0 | 0 | |
ROIC | 0 | -0.54 | 0 | 0 | 0 | |
Return on tangible assets | 0 | -0.17 | 0 | 0 | 0 | |
Graham Net | 0 | 0.07 | 0 | 0 | 0 | |
Working capital | 18.99M | 14.02M | 10.27M | 22.67M | 27.88M | |
Tangible asset value | 34.97M | 31.46M | 13.95M | 39.66M | 13.27M | |
Net current asset value | 14.78M | 12.02M | 9.27M | 21.72M | 8.12M | |
Invested capital | 0.03 | 0.03 | 0.04 | 0.03 | 0.39 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 4.86M | 5.13M | 4.32M | |
Average inventory | 0 | 0 | 251.5K | 298K | 152.5K | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | -0.22 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
LBPSW Frequently Asked Questions
What is 4D pharma plc stock symbol ?
4D pharma plc is a GB stock and trading under the symbol LBPSW
What is 4D pharma plc stock quote today ?
4D pharma plc stock price is $0.0035 today.
Is 4D pharma plc stock public?
Yes, 4D pharma plc is a publicly traded company.